Peel and Wax Consult with a Suspicious Cheek Lesion
A 41-year-old client, Fitzpatrick type IV, books a 'glow' facial that includes a 30% glycolic peel, microdermabrasion, and upper-lip wax. Her intake form lists tretinoin 0.05% nightly, stopped 3 days ago; a superficial peel at another spa 10 days ago; a return from Cancún 4 days ago; doxycycline for acne; and a history of cold sores. On visual assessment, the nose is lightly peeling, and there is a 6 mm pearly papule with a telangiectatic border on the left cheek that she says 'bleeds when I towel off.' She wants the peel 'stronger' because she is attending a gala in 5 days. She has no known allergies. The esthetician has a 60-minute slot and a 15% TCA peel in the cabinet, which the client points to and requests.
1. List the contraindications and relative cautions for this service, and explain how each changes the treatment plan.
Read the worked answer
Absolute contraindications to the peel and microdermabrasion today: tretinoin stopped only 3 days ago (typically 7–14 days of washout is needed, longer for deeper peels); a superficial peel 10 days ago (the skin barrier is still recovering); recent sun exposure with light peeling 4 days ago; doxycycline (photosensitivity and irritation risk); active peeling; and the undiagnosed cheek lesion. Relative cautions: Fitzpatrick IV has a higher risk of post-inflammatory hyperpigmentation; cold-sore history raises the risk of herpes reactivation with any resurfacing or waxing; the gala in 5 days leaves no recovery window.
Plan change: no 30% glycolic, no microdermabrasion, no 15% TCA, and no lip wax today. Substitute a gentle cleanse, hydration, and broad-spectrum SPF; discuss a later series after washout and after the lesion is evaluated. Rebook at least 2 weeks after tretinoin is stopped and after sun exposure has resolved.
2. What should the esthetician do about the cheek lesion, and what should she say to the client?
Read the worked answer
The esthetician cannot diagnose, but she can describe and refer. The pearly appearance, telangiectatic border, and bleeding with towel friction are warning features that warrant a dermatology evaluation. She should note the exact location, size (6 mm), color, border, and the client's report of bleeding; photograph only with written consent and per salon policy; do not extract, massage, peel, or wax over it; do not call it cancer. Say: 'This is outside my scope to diagnose, but because it bleeds, I want you to have a dermatologist look at it before any resurfacing treatment.' Document the referral and the client's response. If the client declines, record that too.
3. The client insists on the 15% TCA peel and says she will sign a release. How should the esthetician handle this, and is a release enough?
Read the worked answer
She should still decline. A release is evidence of a conversation, not a license to breach the standard of care. The combination of recent tretinoin, a recent peel, recent sun, doxycycline, and active peeling makes a 15% TCA peel predictably risky, and the 5-day event deadline means any complication - post-inflammatory hyperpigmentation, frosting, infection, or a cold sore - would be visible. She should also verify whether TCA at that concentration is within the Maryland esthetician scope and salon protocol; if it requires physician supervision, that must be in place. Offer a safe alternative and rebook. Document the refusal, the reasons, and the alternatives. If the client insists on immediate resurfacing, refer her to a dermatologist or a physician-supervised setting.